The FDA has delayed approval of Cephalon's Nuvigil for jet lag by three months, saying it needs more time to review the company's application before it can approve an additional indication. Nuvigil is already approved as a treatment for sleep disorders. Article [1]
Links:
[1] http://www.reuters.com/article/idUSN2125792320091221